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Cancer in Women
Cancer is emerging as a public health problem among an array of non-communicable 
diseases. The common cancers in women are breast, cervix uteri, colo-rectum, ovary, 
corpus uteri, lung and oral cavity.  Breast cancer (BC) is the common cancer (20-30% 
of all cancers in women) and the leading cause of cancer death in women worldwide. 
About half of the BCs and 60% of the deaths are estimated to occur in economically 
developing countries. In most of the registries in India, BC is the commonest cancer 
with the highest incidence of nearly 50 per 100,000 women in Trivandrum. Half of this 
cancer is reported in <50 years of age and it exercises adverse inﬂuence on the 
productive role of women in the society. The factors that contribute to the international 
variation in BC incidence rates are largely due to the differences in reproductive and 
hormonal factors and the availability of early detection services. 
Gynecological cancers account 15-30% of all cancers in women. Cervix uteri cancer 
(CC) is the 3rd most common cancer affecting women worldwide, the most common 
cancer among women in several less developed countries and 2nd common cancer in 
India. During last few decades, this cancer incidence has been decreased in India.  
Signiﬁcant declines in CC are likely due to changes in marriage and family planning, 
supported by underlying improvements in education and socioeconomic status. In spite 
of decreasing incidence of this cancer, gynecologic cancers have increased in India. 
Among these, ovary and corpus uteri cancers are the major contributors. Ovarian 
cancer (OC) has emerged as one of the common malignancies affecting women in India 
and is the 5th common cancer in India (4th common in Trivandrum). A steady increase 
has been observed in OC incidence in several registries including Trivandrum. More 
than 50% of women with OC are under the age of 50 years. The risk of it increases in 
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ABSTRACT
INTRODUCTION
 Cancer is emerging as a public 
health problem among women in an array 
of non-communicable diseases. Among 
women, it was estimated that 6.7 million 
new cancer cases and 3.6 million cancer 
deaths occurred worldwide in 2012 and 
common cancer sites were breast (26%), 
colo-rectum (9%), lung (9%), cervix uteri 
(8%) and corpus uteri (5%) (1). In India, 
based on the 27 cancer registries 
functioning under the national cancer 
r e g i s t r y  p r o g r a m m e  ( N C R P )  o f 
Government of India, a total of 6,95,693 
women cancer cases were estimated for 
the year 2015 and common cancer sites 
were breast (27%), cervix uteri (23%), 
colo-rectum (5%), ovary (5%) and oral 
cavity (4%). Estimated burden of these 
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women who have ovulated more over their lifetime. This includes those who begin 
ovulation at a younger age or reach menopause at an older age. Other risk factors 
include hormone therapy after menopause, fertility medication and obesity. Factors 
that decrease risk include hormonal birth control, tubal ligation, and breast feeding. 
Efforts are to be made to detect ovarian cancer at an early stage by educating population 
about the risk factors. Corpus uteri cancers (CUC) are most common in western 
countries but are becoming more common in Asia. In India, the highest CUC incidence 
rates are observed in Trivandrum and its incidence has been increasing. Presently, it is 
the 5th common cancer among women in Trivandrum, 75% of women are over the age 
of 50 years. The risk factors of CUC include obesity, diabetes mellitus, BC, use of 
tamoxifen, never having had a child, late menopause and high levels of estrogen. 
Colo-rectal cancer (CRC) is the 2nd most common cancer in women world-wide. The 
burden of CRC has risen rapidly in some economically developed Asian countries like 
Japan, South Korea and Singapore. In India, the highest CRC incidence rates are 
observed in Trivandrum and its incidence has been increasing. Presently, it is the 5th 
common cancer among women in Trivandrum. The major factors include certain 
dietary practices and family history of cancer. Individuals with a family history of colon 
cancer, especially if more than one relative has had the disease, are at increased risk of 
CRC. Other common cancers in women are tobacco-related cancers such as oral cavity 
(lip, tongue and mouth) and lung. Declining trends in mouth cancer has been reported 
in India. 
Results on the burden, trends in incidence & mortality, risk factors of breast, cervix 
uteri, ovary and corpus uteri colo-rectal, lung and oral cavity cancers will be presented.
Keywords : Cancer in women, breast cancer, cervix uteri cancer, corpus uteri cancer, 
ovarian cancer, colo-rectal cancer, gynecological cancer, hormone therapy, 
menopause, oral cavity cancer.
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cancers in India were 134,214 female 
breast; 97,909 cervix uteri; 45,231 ovary; 
25, 395 corpus uteri, 30, 309 colo-rectum; 
28,542 lung and 39,090 oral cavity for the 
year 2015 (2). Incidence, mortality, trends 
and etiology of cancers such as breast, 
cervix uteri, ovary, corpus uteri, colo-
rectum, lung and oral cavity are described 
brieﬂy.
 Breast cancer (BC) is the most 
common cancer among women in both 
more developed (MDC) (794,000 cases) 
and less developed countries (LDC) 
(883,000 cases, among these 16.4% are 
from India). Age-standardized incidence 
rates (ASR) (per 100,000) varied nearly 
four-fold across the world regions, with 
rates ranging from 27 in Middle Africa 
and Eastern Asia to 96 in Western Europe 
(1). The rate has decreased in the US and 
many other developed countries since 
early 2000s (3). However, both incidence 
and mortality rates have increased in 
LDCs during the last two decades (4-8). 
More than 60% of BCs are diagnosed at 
the local stage in the US (SEER). 
Conversely, a very high proportion of 
cases in the developing world are detected 
in late stages (9, 10). More than 70% of 
BC patients in high-income countries are 
diagnosed in stages I and II whereas only 
20%-50% patients in low- and middle-
income countries are diagnosed in these 
earlier stages (11). 
 In India, BC is the commonest 
cancer in most of the registries with the 
highest incidence of nearly 50 per 100,000 
women in Trivandrum. Time trends in 
incidence in some areas in India have 
increased steadily for decades, although 
the reasons are not well understood (4, 12-
14). Pre-menopausal BC comprised 
substantially a higher proportion of all 
incident breast cancers in LDCs (average 
47.3%) compared to MDCs (average 
18.5%). Speciﬁcally, 48.4% of BC 
patients are diagnosed before age 50 years 
in India while corresponding proportions 
were 21.5%, 19.1% and 15.9% in 
Australia, UK and Denmark (15). 
 Some reproductive factors such as 
early age at menarche, late age at 
menopause, decreased total duration of 
breast feeding, obesity and decreased 
p h y s i c a l  a c t i v i t y  h a v e  s t r o n g e r 
association with the risk of developing 
post-menopausal BC (16-21). Changes in 
reproductive and life-style factors mainly 
affect post-menopausal women whereas 
genetic factors probably play a more 
signiﬁcant role in young women, though 
these factors alone cannot account for 
international variation in risk (22). 
Compared to post-menopausal women, 
BC in young women tend to display more 
aggressive features, and as a consequence 
a higher cause-speciﬁc mortality (23-25).
 Globally, gynecological cancers 
account for 15-25% of all cancers in 
women. These cancers rank high in 
incidence and can affect women of all 
ages (26). The incidence and mortality 
rates of gynecologic cancers in Asian 
countries differ from those in Western 
countries (1). Cervix uteri cancer remains 
a major health problem in East Asia, 
although incidence rates have been 
decreasing. Behavioral factors such as 
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delayed and reduced childbearing, use of 
hormone-replacement therapy and 
reduced physical activity have also 
become more prevalent among East Asian 
women (27). 
 Cervix uteri cancer (CC) is the 
3rd most common cancer affecting 
women with an estimated 528,000 new 
cases in 2012 worldwide. A large majority 
(around 85%) of the global burden occurs 
in the less developed regions, where it 
accounts for almost 12% of all female 
cancers. During the past few decades, 
incidence of this cancer has been 
decreased world-wide including India 
(28). Even though the relative importance 
of this disease has declined, the annual 
number of cases has increased. There were 
an estimated 266,000 deaths from CC 
worldwide in 2012, accounting for 7.5% 
of all female cancer deaths (1). It is the 2nd 
common cancer in India with highest ASR 
in Pazhighat (22.5 per 100,000) followed 
by Mizoram (20 per 100,000) in North 
east regions. However in Kerala, low 
incidence has been reported both in 
Trivandrum and Kollam (ASR: 7 per 
100,000 in both areas) (2). The most 
important risk factor for CC is infection 
with the Human Papillomavirus (HPV). 
Women who smoke or whose mothers 
were given diethylstilboestrol during 
pregnancy are also at increased risk for 
this cancer. The decline in incidence has 
been attributed to a combination of 
factors, including improved genital 
hygiene, changes in marriage and family 
planning methods, improved treatment 
modalities and the beneﬁcial effects of 
population-based cytological screening 
programmes. Screening via regular 
gynaecologic examinations and Pap 
smear  fo l lowed  by  t rea tment  o f 
precancerous abnormalities decreased the 
incidence and mortality of CC (29). 
 Over  the  years  in  spi te  of 
decreasing incidence of CC, gynecologic 
cance r s  have  i nc r ea sed  and  a r e 
contributing about 30% of total cancers 
among women. Among these, ovary and 
corpus uteri cancers are the major 
contributors. The American Cancer 
Society estimated 88,750 new cases of 
female genital system cancers in the US in 
2012, of which 81,580 cases (78%) belong 
to the cancers of the corpus uteri (47,130; 
53.1%) and ovary (22,280; 25.1%). 
Estimated deaths for these cancers were 
8010 and 15,500 respectively (26).
 Ovarian cancer (OC) (239,000 
cases and 152,000 deaths) is the 7th 
common cancer and the 8th cause of death 
from cancer in women (3.6% of cases and 
4.3% deaths). Incidence rates are high in 
more developed regions, with rates in 
these areas exceeding 15 and lowest in 
Sub-Saharan Africa with rates below 5 per 
100,000 (1). It has emerged as one of the 
common malignancies affecting women 
in India (2). A steady increase has been 
observed in incidence in several cancer 
registries including Trivandrum in India 
(30). More than 50% of women with OC 
are under the age of 50 years. The risk of it 
increases in women who have ovulated 
more over their lifetime. Other risk factors 
i n c l u d e  h o r m o n e  t h e r a p y  a f t e r 
menopause, fertility medication and 
obesity. Factors that decrease risk include 
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hormonal birth control, tubal ligation and 
breast feeding (29, 31).
 Corpus uteri cancers (CUC) are 
more common in western countries but are 
becoming common in Asia. A total of 
320,000 new cases (4.8% of cancers in 
women) and 76,000 deaths (2.1% of 
cancer deaths in women) were reported 
world-wide. The highest incidence rates 
(ASR) were estimated in Northern 
America (19.1 per 100,000) and Northern 
and Western Europe (12.9–15.6). Rates 
are low in South-Central Asia (2.7) and 
most of Africa (<5 per 100,000). Mortality 
rates ranged between 0.9 per 100,000 in 
Northern Africa and 3.8 per 100,000 in 
Melanesia (1). Increasing incidence rates 
of this disease have been reported in India 
(32). Nationally, the highest CUC 
inc idence  r a t e s  a re  obse rved  in 
Trivandrum (6 per 100,000). It is the 5th 
common cancer among women in 
Trivandrum (2). Eighty percent of women 
with CUC are over the age of 50 years. The 
risk factors for it include obesity, diabetes 
mellitus, breast cancer, use of tamoxifen, 
nulliparity, late menopause and high 
levels of estrogen (29, 33). 
 Colo-rectal cancer (CRC) is the 
2nd most common cancer in women 
(614,000 cases, 9.2% of the total) world-
wide. There is a ten-fold geographical 
variation in incidence (55% of the cases in 
more developed regions) across the world, 
the highest estimated rates per 100,000 
were in Australia/New Zealand (ASR: 
32.2), and the lowest in Western Africa 
(ASR: 3.8) (1). The burden of CRC has 
risen rapidly in some economically 
developed Asian countries (34) closing 
the gap to the western, industrialized 
populations. Economically transitioning 
countries have reported rapid increases in 
CRC incidence rates, with rates in the 
Czech Republic, Slovakia and Japan 
exceeded  those  i n  l ongs t and ing 
economically developed countries such as 
the United States, Canada, and Australia, 
these increases are thought to reﬂect 
changing dietary and physical activity 
patterns. In contrast, CRC rates remained 
stable or slightly increased from registries 
in majority of developed countries such as 
those in France, Italy, England, Germany, 
and Switzerland and decreased in the 
United States (35, 36). 
 In  India ,  the  h ighes t  CRC 
incidence rates (9 per 100,000) are 
observed in Trivandrum and its incidence 
has been increasing. Presently, it is the 5th 
common cancer among women in 
Trivandrum (2). The major risk factors 
include certain dietary practices, reduced 
physical activity and family history of 
cancer. Individuals with a family history 
of colon cancer, especially if more than 
one relative has had the disease, are at 
increased risk of CRC. Time trends in 
incidence in some areas in India have 
increased steadily for decades, although 
the reasons are not well understood (37, 
38). Given the large population of India, 
even subtle change in incidence can lead 
to a substantial burden of disease. CRC 
can often be prevented through regular 
screening, which can identify and remove 
precancerous polyps. The cause of CRC is 
not known, but age, presence of adenomas 
in the colon and rectum, family history of 
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CRC in a ﬁrst-degree relative, smoking 
and a diet high in animal fat increase the 
risk of developing the disease (29).
 Lung cancer (LC) is the 3rd 
common cancer among women world-
wide. In women, the incidence rates are 
generally lower and the geographical 
pattern is a little different, mainly 
reﬂecting different historical exposure to 
tobacco smoking. Thus the highest 
estimated age-standardized rates (per 
100,000) are in Northern America (33.8) 
and Northern Europe (23.7) with a 
relatively high rate in Eastern Asia (19.2) 
and the lowest rates again in Western and 
Middle Africa (1.1 and 0.8 respectively) 
(1). 
 In India, LC was the leading site 
among tobacco related cancers in 11 
registries among women, all the three 
areas of Mizoram namely, Aizawl District 
(40.8), Mizoram State (29.3) and 
Mizoram excluding Aizawl District (21.1) 
were at the top followed by Papumpare 
District (16.3) has the highest incidence 
rate among women (2). Rates of LC in 
women have been increasing since 1965, 
with a very modest reduction beginning 
only in the year 2000 (39). Smoking 
remains prevalent, especially in younger 
women (40). Smoking is the predominant 
cause of LC, and most cancers occur in 
people who smoke. In addition, non-
smoking women are more likely than men 
to be subject to second-hand smoke from a 
smoking spouse. Tobacco smoke further 
increases the chance of developing the 
disease when other environmental risk 
factors are present. Other substances that 
can cause LC, are asbestos, radon, arsenic, 
chromium, nickel, and tar. However, the 
impact of these chemicals on the 
incidence of LC is small compared to 
smoking (29).
 Oral cavity cancer  (OCC) 
accounted for 101,398 new cases in 2012 
among women world-wide. The region 
with the highest incidence was South 
Central Asia (6 per 100,000) and the 
lowest rates in Western Asia(1.0 per 
100,000) (1). OCC is common in India 
and is the 5th leading cancer among 
women. OCC can develop in any part of 
the oral cavity, the most common sites 
being the tongue, lip, and ﬂoor of the 
mouth. Rates of OCC are more than two 
times higher in men than in women. 
Declining trends in mouth cancer 
incidence have been in India (2) (NCRP 
2016). Studies showed that tobacco use, 
alcohol consumption, prolonged sun 
exposure and infection with HPV are the 
factors increase the risk of developing oral 
cancer (29).
 In conclusion, cancer is emerging 
as a public health problem among women. 
Most of the common cancers are showing 
an increasing trend in incidence except 
cancer of the cervix uteri and mouth. More 
than 50% of the cancers in India are 
reported in <50 years of age and mostly in 
late stages. Hence it exercises adverse 
inﬂuence on the productive role of women 
in the society. Public health efforts are to 
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be made to understand the reasons for the 
striking increase in incidence of cancers 
and to promote education and awareness 
to facilitate diagnosis at earlier stage.
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